EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers

Maria Pallozzi, Valeria De Gaetano, Natalia Di Tommaso, Lucia Cerrito iD, Francesco Santopaolo iD, Leonardo Stella iD, Antonio Gasbarrini iD, Francesca Romana Ponziani iD

Nutrients · 22.07.2024 · 16 (14) · 2372

DOI: 10.3390/nu16142372 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 22.07.2024. Verfasst von Maria Pallozzi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Liver Unit, Centro Malattie dell'Apparato Digerente (CEMAD), Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli Istit…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Liver Neoplasms, Dysbiosis, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 194 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatobiliary malignancies, which include hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), are the sixth most common cancers and the third leading cause of cancer-related death worldwide. Hepatic carcinogenesis is highly stimulated by chronic inflammation, defined as fibrosis deposition, and an aberrant imbalance between liver necrosis and nodular regeneration. In this context, the gut–liver axis and gut microbiota have demonstrated a critical role in the pathogenesis of HCC, as dysbiosis and altered intestinal permeability promote bacterial translocation, leading to chronic liver inflammation and tumorigenesis through several pathways. A few data exist on the role of the gut microbiota or bacteria resident in the biliary tract in the pathogenesis of CCA, and some microbial metabolites, such as choline and bile acids, seem to show an association. In this review, we analyze the impact of the gut microbiota and its metabolites on HCC and CCA development and the role of gut dysbiosis as a biomarker of hepatobiliary cancer risk and of response during anti-tumor therapy. We also discuss the future application of gut microbiota in hepatobiliary cancer management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeLiver NeoplasmsDysbiosisCarcinoma, HepatocellularCholangiocarcinomaHumansBile Duct NeoplasmsBile Acids and SaltsLiverAnimalsCarcinogenesis

Stichwörter der Autor:innen

cholangiocarcinomagut microbiotagut–liver axishepatocellular carcinomaimmunotherapyinflammation

Substanzen

Bile Acids and Salts

Autor:innen und Institutionen

  • Liver Unit, Centro Malattie dell'Apparato Digerente (CEMAD), Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli Istituto di Ricovero e Cura a Carattere Scientifico, IRCCS, 00168 Rome, Ita…
  • Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

ORCID-Profile: Lucia Cerrito, Francesco Santopaolo, Leonardo Stella, Antonio Gasbarrini, Francesca Romana Ponziani

Zitieren

APA

Pallozzi, M., De Gaetano, V., Di Tommaso, N., Cerrito, L., Santopaolo, F., Stella, L., Gasbarrini, A., & Ponziani, F. R. (2024). Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers. Nutrients, 16(14), 2372. https://doi.org/10.3390/nu16142372

Vancouver

Pallozzi M, De Gaetano V, Di Tommaso N, Cerrito L, Santopaolo F, Stella L, et al. Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers. Nutrients. 2024;16(14):2372. doi:10.3390/nu16142372

BibTeX
@article{Pallozzi2024,
  author = {Pallozzi, Maria and De Gaetano, Valeria and Di Tommaso, Natalia and Cerrito, Lucia and Santopaolo, Francesco and Stella, Leonardo and Gasbarrini, Antonio and Ponziani, Francesca Romana},
  title = {Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {14},
  pages = {2372},
  doi = {10.3390/nu16142372}
}
Kostenlos starten →